Evidence map›Paper›PMID 24586661›Full record

ArticlePloS one2014

Increasing prion propensity by hydrophobic insertion.

Aaron C Gonzalez Nelson, Kacy R Paul, Michelina Petri, Noe Flores, Ryan A Rogge, Sean M Cascarina, Eric D Ross

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Trans-seeding of Alzheimer-related tau protein by a yeast prion.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Composition-based prediction and rational manipulation of prion-like domain recruitment to stress granules.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A glass menagerie of low complexity sequences.Current opinion in structural biology · 2016
    Review
  13. Article
  14. Generating new prions by targeted mutation or segment duplication.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  15. Article
  16. What makes a protein sequence a prion?PLoS computational biology · 2015
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Aaron C Gonzalez NelsonDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Kacy R PaulDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Michelina PetriDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Noe FloresDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Ryan A RoggeDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Sean M CascarinaDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Eric D RossDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, United States of America.
Colorado State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prion formation involves the conversion of proteins from a soluble form into an infectious amyloid form. Most yeast prion proteins contain glutamine/asparagine-rich regions that are responsible for prion aggregation. Prion formation by these domains is driven primarily by amino acid composition, not primary sequence, yet there is a surprising disconnect between the amino acids thought to have the highest aggregation propensity and those that are actually found in yeast prion domains. Specifically, a recent mutagenic screen suggested that both aromatic and non-aromatic hydrophobic residues strongly promote prion formation. However, while aromatic residues are common in yeast prion domains, non-aromatic hydrophobic residues are strongly under-represented. Here, we directly test the effects of hydrophobic and aromatic residues on prion formation. Remarkably, we found that insertion of as few as two hydrophobic residues resulted in a multiple orders-of-magnitude increase in prion formation, and significant acceleration of in vitro amyloid formation. Thus, insertion or deletion of hydrophobic residues provides a simple tool to control the prion activity of a protein. These data, combined with bioinformatics analysis, suggest a limit on the number of strongly prion-promoting residues tolerated in glutamine/asparagine-rich domains. This limit may explain the under-representation of non-aromatic hydrophobic residues in yeast prion domains. Prion activity requires not only that a protein be able to form prion fibers, but also that these fibers be cleaved to generate new independently-segregating aggregates to offset dilution by cell division. Recent studies suggest that aromatic residues, but not non-aromatic hydrophobic residues, support the fiber cleavage step. Therefore, we propose that while both aromatic and non-aromatic hydrophobic residues promote prion formation, aromatic residues are favored in yeast prion domains because they serve a dual function, promoting both prion formation and chaperone-dependent prion propagation.

Indexed as

Hydrophobic and Hydrophilic InteractionsAmino Acid SequenceAmyloidAsparagineBlotting, WesternComputational BiologyGlutamineMolecular Sequence DataMutagenesisMutationPrionsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSequence Homology, Amino AcidTyrosineAmyloidAsparagineGlutaminePrionsSaccharomyces cerevisiae ProteinsTyrosine

Identifiers

PMID24586661
PMCPMC3930707
OpenAlexW1968726777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.